Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HBL-100
Unknown
Unknown
Fascaplysin
CDK4
CDK
7429.084
uM
0.51395
0.68198
-0.7688 -0.7596 3.2661 0.5289
0.9995
2.2510
HBL-100
Unknown
Unknown
Geldanamycin
HSP90
HSP90
9226.012
uM
0.02301
0.02808
-0.3154 -0.1486 1.3062 0.7103
0.9670
2.5039
HBL-100
Unknown
Unknown
Geldanamycin
HSP90
HSP90
7807.04
uM
0.03553
0.04820
-0.3708 -0.2711 1.4204 0.7397
0.9883
2.1435
HBL-100
Unknown
Unknown
Gemcitabine
DNA replication
DNA replication
7807.011
uM
0.02882
0.03612
-0.4577 -0.4250 2.7264 0.9196
0.9992
2.1620
HBL-100
Unknown
Unknown
GSK1070916
AURK
AURK
7808.001
uM
0.19841
1.24310
-0.9041 -1.0000 0.5987 0.5723
0.9550
2.5321
HBL-100
Unknown
Unknown
17-AAG
HSP90
HSP90
7807.04
uM
1.67060
4.14870
-0.7759 -0.7682 1.0232 0.4211
0.9891
2.1435
HBL-100
Unknown
Unknown
Bortezomib
Proteasome
Proteasome
7429.074
uM
0.21399
0.25848
-0.7951 -0.7656 4.9167 0.8819
0.9981
2.3375
HBL-100
Unknown
Unknown
(Z)-4-Hydroxytamoxifen
ESR1
7807.016
uM
11.62140
15.50560
-0.8212 -0.8219 3.3715 0.3669
0.9974
2.1516
HBL-100
Unknown
Unknown
(Z)-4-Hydroxytamoxifen
ESR1
7808.016
uM
inf
13.19490
0.5274 0.7135 4.9687 0.0363
0.6432
2.2401
HBL-100
Unknown
Unknown
17-AAG
HSP90
HSP90
7808.05
uM
0.95232
1.51340
-0.4445 -0.4552 1.3976 0.4994
0.9942
2.5177
HBL-100
Unknown
Unknown
5-FU
TYMS
TYMS
7808.017
uM
153.52750
267.86840
-0.0890 -0.1730 0.5339 0.3993
0.9832
2.4168
HBL-100
Unknown
Unknown
AG1024
IGF1R
RTK
7429.066
uM
inf
inf
0.9919 0.9919 0.0000 0.0080
0.0137
2.3904
HBL-100
Unknown
Unknown
AG1478
EGFR
ErbB
7808.016
uM
inf
inf
0.9515 0.9515 0.0000 -0.0168
0.0597
2.2401
HBL-100
Unknown
Unknown
Carboplatin
DNA cross-linker
DNA cross-linker
7808.011
uM
91.64120
178.22410
-0.9131 -0.9831 1.6346 0.3085
0.9967
2.4301
HBL-100
Unknown
Unknown
Carboplatin
DNA cross-linker
DNA cross-linker
7807.011
uM
80.29730
142.76360
-0.7730 -0.8163 1.6820 0.3238
0.9983
2.1620
HBL-100
Unknown
Unknown
Cetuximab
EGFR
ErbB
7807.042
uM
inf
inf
1.0098 1.0098 0.0000 -0.0392
-7.7987
2.0250
HBL-100
Unknown
Unknown
Cetuximab
EGFR
ErbB
7808.052
uM
inf
inf
0.9944 0.9944 0.0000 -0.0231
-0.8225
2.4842
HBL-100
Unknown
Unknown
CGC-11047
Polyamine analogue
7808.052
uM
inf
0.72086
0.5882 0.6283 0.8496 0.1837
0.9560
2.4842
HBL-100
Unknown
Unknown
Cisplatin
DNA cross-linker
DNA cross-linker
7807.017
uM
inf
inf
-0.4695 -0.4695 0.0000 0.2218
0.4545
2.2007
HBL-100
Unknown
Unknown
Cisplatin
DNA cross-linker
DNA cross-linker
9226.021
uM
8.73650
13.53040
-0.6894 -0.7018 2.0049 0.3883
0.9995
2.5142
HBL-100
Unknown
Unknown
CPT-11
TOP1
TOP
7808.043
uM
3.95580
3.81630
-0.1647 0.0821 5.0000 0.2428
0.8707
2.3907
HBL-100
Unknown
Unknown
Doxorubicin
TOP2
TOP
7808.043
uM
0.03423
0.04488
-0.2801 -0.5530 2.7489 0.9385
0.9153
2.3907
HBL-100
Unknown
Unknown
Doxorubicin
TOP2
TOP
9226.034
uM
0.06059
0.09525
-0.8190 -0.7193 1.9706 0.9033
0.9973
2.6175
HBL-100
Unknown
Unknown
Methotrexate
DHFR
Metabolism
7429.084
uM
inf
0.12857
0.6858 0.7716 5.0000 0.1377
0.8694
2.2510
HBL-100
Unknown
Unknown
Ispinesib
KSP
Kinesin
7429.067
uM
0.02923
0.03665
-0.8592 -0.4894 3.0166 0.7627
0.9592
2.2169